信息搜索
信息关键字：药
  
『查询2022年信息』  『查询2021年信息』  『查询2020年信息』  『查询2019年信息』  『查询2018年信息』  『查询2017年信息』  『查询2016年信息』
『查询2015年信息』  『查询2014年信息』  『查询2013年信息』  『查询2012年信息』  『查询2011年信息』  『查询2010年信息』  『查询2009年信息』

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]

·翰宇药业三项发明专利获国家知识产权局授权2023-12-29 17:18:53
·一心堂：拟不超840万元收购宜骏药业所持10家门店资产及其存货2023-12-27 23:10:47
·昆药集团：未来公司将锚定“银发经济健康第一股”的战略核心2023-12-27 21:13:03
·股票行情快报：中国医药（600056）12月27日主力资金净卖出110.91万元2023-12-27 19:22:56
·IPO动态：施美药业拟在深交所创业板上市募资6.08亿元2023-12-27 17:00:24
·重药控股：董事长拟以不超100万元增持公司股份2023-12-27 16:46:35
·12月27日莎普爱思涨停分析：眼科，医药，民营医院概念热股2023-12-27 16:42:28
·海创药业：口服PROTAC药物HP518片中国临床试验完成首例受试者入组2023-12-27 16:42:20
·华东医药：全资子公司合作开发产品被纳入优先审评2023-12-27 16:25:38
·年内21家四川上市公司公布股权激励计划 近三成来自医药生物行业2023-12-27 16:00:15
·九典制药：取得吲哚美辛凝胶贴膏Ⅲ期临床试验总结报告2023-12-27 15:47:42
·年内21家四川上市公司公布股权激励计划 近三成来自医药生物行业2023-12-27 15:39:36
·医药与健康护理行业信息点评：第50周南方流感阳性率上升趋缓，北方阳性率下降2023-12-27 12:30:10
·昭衍新药（603127）12月26日主力资金净卖出1923.16万元2023-12-27 8:47:02
·药店行业深度研究：处方外流加速，看好头部企业强者恒强2023-12-27 8:18:27
·因流动性收缩未能按时还款 香雪制药再添重大诉讼2023-12-27 2:32:11
·海思科创新药HSK39297片Ⅰ期临床试验首例受试者入组2023-12-26 23:13:12
·股票行情快报：启迪药业（000590）12月26日主力资金净卖出13.35万元2023-12-26 21:45:34
·东宝生物药典二部明胶（代血浆明胶）入选工信部第十批《升级和创新消费品指南（轻工）》名单2023-12-26 20:41:40
·深交所恢复施美药业创业板IPO发行上市审核专注于仿制药、改良型创新药、创新药的产研销2023-12-26 20:02:38

分页[1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] [57] [58] [59] [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] [70] [71] [72] [73] [74] [75] [76] [77] [78] [79] [80] [81] [82] [83] [84] [85] [86] [87] [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] [101] [102] [103] [104] [105] [106] [107] [108] [109] [110] [111] [112] [113] [114] [115] [116] [117] [118] [119] [120] [121] [122] [123] [124] [125] [126] [127] [128] [129] [130] [131] [132] [133] [134] [135] [136] [137] [138] [139] [140] [141] [142] [143] [144] [145] [146] [147] [148] [149] [150] [151] [152] [153] [154] [155] [156] [157] [158] [159] [160] [161] [162] [163] [164] [165] [166] [167] [168] [169] [170] [171] [172] [173] [174] [175] [176] [177] [178] [179] [180] [181] [182] [183] [184] [185] [186] [187] [188] [189] [190] [191] [192] [193] [194] [195] [196] [197] [198] [199] [200] [201] [202] [203] [204] [205] [206] [207] [208] [209] [210] [211] [212] [213] [214] [215] [216] [217] [218] [219] [220] [221] [222] [223] [224] [225] [226] [227] [228] [229] [230] [231] [232] [233] [234] [235] [236] [237] [238] [239]